This conference in Basel brings together pioneers transforming medicine through CRISPR technology. From groundbreaking therapies to ethical implications, attendees will explore all facets of gene-editing applications. Our team will present cutting-edge research and invite discussions on leveraging CRISPR innovations for broader healthcare impact. Join us to collaborate on pioneering projects that redefine the future of genetic medicine.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
